| Application no. and date | 13783363.8 (espacenet) (Federated) (European Patent Register), 20131015 | | Patent/reg. no. and date | DK/EP 2909175, 20170607 | | Publication date | 20150826 | | Priority no. and date | GB 201218640, 20121017, GB 201306881, 20130416 | | EP pub. no. and date |
EP 2909175 20150826 | | Effective date | | | Applicant/owner | Macrophage Pharma Limited, St. Stephens House,
Arthur Road, Windsor
Berkshire SL4 1RU, GB | | Applicant ref. no. | P81702876DK00E | | Inventor | PINTAT, Stéphane, c/o Chroma Therapeutics Limited
93 Innovation Drive
Milton Park
Abingdon
Oxfordshire OX14 4RZ, GB,
DAVIES, Stephen, John, c/oChroma Therapeutics Limited
93 Innovation Drive
Milton Park
Abingdon
Oxfordshire OX14 4RZ, GB,
MOFFAT, David, Festus, Charles, c/o Chroma Therapeutics Limited
93 Innovation Drive
Milton Park
Abingdon
Oxfordshire OX14 4RZ, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4412 (2006.01) , A61P 29/00 (2006.01) , A61P 35/00 (2006.01) , C07D 213/73 (2006.01) | | Title | TERT-BUTYL N-[2-{4-[6-AMINO-5-(2,4-DIFLUORBENZOYL)-2-OXOPYRIDIN-1(2H)-YL]-3,5-DIFLUORPHENYL}ETHYL]-L-ALANINAT ELLER ET SALT, HYDRAT ELLER SOLVAT DERAF | | Int. application no. | GB2013052689 | | Int. publication no. | WO2014060742 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
